Rational biomarker development for the early and minimally invasive monitoring of AML
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP286386
下载链接
链接失效反馈官方服务：
资源简介：
We investigated circulating plasma EVs miRNA from 12 AML patients versus 12 healthy donors to identify a miRNA signature as a potential biomarker for patients with AML. Overall design: Plasma samples were collected from patients or healthy donors, EVs were isolated by serial high-speed centrifugation, total RNA was extracted and used used to generate cDNA libraries and perform a next-generation sequencing using NextSeq500.
创建时间：
2021-12-01
